IL18 and polycystic ovary syndrome: The expression level of IL-18 indicated a reduction in PCOS during post-metformin therapy process and the control groups with BMI > 25 kg/m2 and BMI < 25 kg/m2 than in the patients with PCOS Pre-treatment, but this alteration was not notable (P > 0.05) (Fig 3B).